Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc. The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Lurasidone Hydrochloride tablets in the strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, Alembic Pharmaceuticals said in a regulatory filing. Quoting IQVIA data, Alembic Pharma said Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg have an estimated market size of USD 3.7 billion for the twelve months ending December 2020. Lurasidone Hydrochloride tablets are indicated for treatment of major depressive episodes associated with bipolar I disorder (bipolar depression). Alembic Pharma said it has settled the cas
At present, India has 90,000 ICU beds and almost all are already occupied - when the second wave of the pandemic hasn't even reached its peak yet, says noted surgeon Dr Devi Prasad Shetty
India remains badly placed to tackle the rapid spread of Covid-19 despite several reforms and the unprecedented crisis has highlighted the need to increase investments in the healthcare sector
The Covid-19 vaccination for all people aged 45 years and above commenced from Thursday, the Union Health Ministry said
India saw 72,330 new coronavirus infections being reported in a span of 24 hours, the highest single-day rise so far this year, taking the Covid-19 tally of cases to 12,221,665
Union Health Minister Harsh Vardhan said that seven more Covid-19 vaccine candidates are in stages of clinical trials
India saw 59,118 new coronavirus infections in a day, the highest single day rise so far this year, taking the nationwide Covid-19 tally to 11,846,652
Maharashtra has emerged as the leader in the Covid-19 vaccination drive as it has administered vaccine doses to 4,342,646 people, an official said on Thursday
The Parliament on Wednesday passed the National Commission for Allied and Healthcare Professions Bill, 2021
As anti-virus vaccines become the biggest productivity leap of the 21st century, India could possibly emerge as the destination of choice for products against a larger number of viral diseases
Calling malls, cinema halls and religious places "superspreader" areas, the Delhi government has directed all district magistrates to greatly intensify enforcement of Covid-19 norms in such places
India recorded 47,262 fresh coronavirus cases in a day, the highest single-day rise so far this year, taking the nationwide Covid-19 tally to 1,17,34,058, the Union health ministry said on Wednesday
India recorded 40,715 coronavirus cases in a day, taking the nationwide infection tally to 11,686,796, while the active caseload at 345,377 registered an increase for the 13th day in a row
India saw 46,951new coronavirus infections being reported in a day, the highest so far this year, taking the nationwide tally to 11,646,081, according to the Union Health Ministry data
India saw 40,953 new coronavirus infections being reported in a day, the highest single-day rise recorded in 111 days, taking the nationwide Covid-19 tally to 11,555,284
Most students who tested positive are from other states. Some first contacts with the Covid-19 positive have also tested positive
As many as 35,871 new Covid-19 cases and 17,741 recoveries were reported in India in the last 24 hours, the Union Health Ministry informed on Thursday
India recorded 28,903 new coronavirus infections, the highest so far this year, taking the Covid-19 tally to 11,438,734, according to the Union Health Ministry data updated on Wednesday
In Gurugram a rapid phase of the Covid-19 vaccination drive is being conducted in 89 hospitals
India recorded 22,854 cases of coronavirus infection in a day, the highest in around two-and-half-months, taking the tally of Covid-19 cases to 1,12,85,561